FDA to lower number of trials required for drug approvals

Shift could speed development but raises concerns about insufficient evidence on efficacy and safety.  

December 4, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Evan Vucci/AP STAT+ | FDA to lower number of trials required for approval of drugs, other medical products FDA is moving to require one clinical study, not the standard two, for medical products before consideration for approval, commissioner says. By Lizzy Lawrence STAT+ | Tracy Beth Høeg, Makary aide who investigated Covid vaccines, to lead FDA drug center Høeg will be the fifth person to lead the center this year, and her appointment comes after Richard Pazdur's abrupt retirement. By Lizzy Lawrence and Chelsea Cirruzzo STAT+ | Vinay Prasad, FDA's vaccine regulator, waves off criticism in closed-door remarks Vinay Prasad pushes back on criticism of his vaccine policy changes, morale issues at the FDA, and his role in recent drug-approval turbulence. By Damian Garde and Lizzy Lawrence Molly Ferguson/STAT STAT+ | What to expect at the ASH meeting, and some thoughts on the FDA's Richard Pazdur In this week's edition of "Adam's Biotech Scorecard," Adam addresses the latest FDA twist and gets ready for the American Society of Hematology meeting. By Adam Feuerstein STAT+ | Paradigm Health, seeking to use AI to enroll clinical trials, partners with Roche The AI startup announced it has raised another round of funding and is acquiring a business from Flatiron Health. By Matthew Herper CDC vaccine advisers appear likely to recommend delaying hepatitis B vaccine birth dose CDC vaccine panel appears prepared to recommend scrapping universal hepatitis B birth dose, a shift experts warn could trigger a surge in chronic infections in children. By Helen Branswell, Daniel Payne, and Chelsea Cirruzzo

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser